Product Name | MF | CAS | Details |
---|
Betamethasone 17-butyrate | C26H35FO6 | 5534-14-5 | Details |
21-Acetyloxy DeschloroMoMetasone Furoate | C29H33ClO8 | 83897-05-6 | Details |
Terazosin impurity | C19H27N5O4 | 1260939-66-9 | Details |
Bupivacaine Impurity 12 | C18H28N2O | 2125995-25-5 | Details |
Moxifloxacin Impurity 62 | C21H24FN3O4 | 855661-74-4 | Details |
5-Bromo-1-(2-fluorophenyl)-2-pentanone | C11H12BrFO | 1373350-56-1 | Details |
1,6-2-HYDROXYBENZOYLAMINOHEXANE | C20H24N2O4 | 20073-95-4 | Details |
Hydrocortisone Impurity 38 | C21H28O4 | 10184-70-0 | Details |
Dexamethasone Impurity 9 | C22H27FO6 | 84449-15-0 | Details |
Dotinurad Impurity 23 | C9H8Cl2O3 | 24295-27-0 | Details |
Cabozantinib impurity 51 | C10H10FNO | 2354-89-4 | Details |
Methyl (2E)-3-Cyclopentylprop-2-Enoate | C9H14O2 | 136823-41-1 | Details |
Baricitinib Impurity 9 | C13H15N5O | 1911644-33-1 | Details |
Dapoxetine impurity | C19H16O2 | 126113-24-4 | Details |
Safinamide Impurity 18 | C24H24F2N2O2 | 1000370-28-4 | Details |
tert-butyl (R)-(1-((4-methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate | C20H28N4O2 | 2514949-81-4 | Details |
16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate | C23H28O6 | 77017-20-0 | Details |
Betamethasone Valerate EP Impurity H | C27H37ClO6 | 52619-18-8 | Details |
1-P-CHLOROPHENYL-1-CYCLOHEXANOL | C12H15ClO | 17380-83-5 | Details |
Montelukast Impurity 26 | C41H46ClNO5S2 | 1242260-05-4 | Details |
Idarubicin Impurity 6 | C24H23N3O11 | 196512-07-9 | Details |
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide | C13H19ClN4O3 | 2037385-84-3 | Details |
Rivaroxaban Impurity 103 | C8H10ClNO3S | 721401-51-0 | Details |
Clopidogrel | C15H16ClNO2S | 1314028-89-1 | Details |
Betamethasone 9,11-Epoxide Propionate | C25H32O6 | 205105-83-5 | Details |
Prednisone 21-Aldehyde | C21H24O5 | 70522-55-3 | Details |
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | C20H17NO3 | 72901-16-7 | Details |
Mometasone Furoate Impurity V | C29H32O8 | 109183-56-4 | Details |
Tipiracil Impurity 2 | C9H10ClN3O3 | 2101241-71-6 | Details |
(R)-7-(Benzyloxy)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | C31H25F2N3O4S | 1985606-53-8 | Details |
Betamethasone Impurity 3 | C24H32O6 | 18769-24-9 | Details |
Benzoic acid, 4-bromo-3-methyl-, butyl ester | C12H15BrO2 | 1857027-20-3 | Details |
Azathioprine Impurity 2(Azathioprine EP Impurity B) | C5H4N4S | 157930-13-7 | Details |
11β-hydroxy-3,20-dioxopregn-4-en-21-al | C21H28O4 | 20287-97-2 | Details |
FLUOROMETHOLONE IMPURITY 6 | C22H29FO5 | 382-52-5 | Details |
Clopidogrel Impurity 13 HCl;methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride | C16H16ClNO5S2 | 2173294-69-2 | Details |
Sorafenib Impurity 57 | C7H6ClF3N2 | 1804875-27-1 | Details |
CINACALCET-001-R | C11H11BF4N4O | 1630761-22-6 | Details |
Bisacodyl Impurity 1 | C18H15NO2 | 13004-51-8 | Details |
Olmesartan Medoxomil Impurity 17 | C53H54N12O8 | 1418133-31-9 | Details |
Cabozantinib Impurity 42 | C9H8FNO3 | 95262-10-5 | Details |
Beclometasone Dipropionate EP Impurity O | C28H36Cl2O6 | 14527-61-8 | Details |
Fluticasone propionate Impurity K | C25H31F3O6 | 1174034-79-7 | Details |
Pregna-1,4-diene-3,20-dione,17-hydroxy- | C21H28O3 | 2477-61-4 | Details |
CCMO-48 | C20H13F4N5O2S | 1332391-11-3 | Details |
Butylphthalide impurity | C12H13NO | 20871-40-3 | Details |
Budesonide Impurity 11 | C21H26O5 | 39672-76-9 | Details |
Tinidazole Impurity B | C8H13N3O4S | 25459-12-5 | Details |
1-(3-amino-4,5-dimethoxyphenyl)ethan-1-one | C10H13NO3 | 134611-49-7 | Details |
Remdesivir Impurity 44 | C27H35N6O8P | 2096990-00-8 | Details |
Remdesivir-010-S | C33H31N5O4 | 1369903-46-7 | Details |
1,3-Benzodioxole-5-carboxylic acid, 4-bromo-7-(phenylmethoxy)-, methyl ester | C16H13BrO5 | 142531-44-0 | Details |
11β-hydroxy-16α,17α-isopropylidenedioxy-3-oxo-9α-fluoroandrosta-1,4-diene-17β-carboxylic acid | C23H29FO6 | 3800-28-0 | Details |
N,N-bis((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)pyridine-3-sulfonamide | C27H22F2N4O2S | 2514957-29-8 | Details |
Articaine-013 | C9H11NO3S | 125088-93-9 | Details |
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | C22H19NO4 | 111664-35-8 | Details |
Fluocinolone Acetonide EP Impurity B | C23H28F2O6 | 65751-34-0 | Details |
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate | C15H20N2O6 | 144978-05-2 | Details |
synthesis-20 | C13H26N2O2 | 1873303-87-7 | Details |
4-(aminomethyl)-2-chlorophenol hydrobromide | C7H9BrClNO | 859517-85-4 | Details |
Fluticasone Impurity L | C25H32F2O6 | 59860-80-9 | Details |
(3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine | C13H18ClN5 | 2504210-32-4 | Details |
Fluticasone IMpurity | C27H30F2O6S | 397864-58-3 | Details |
Acotiamide Impurity | C20H21N2NaO4S | 198470-83-6 | Details |
Betamethasone Impurity 8(Betamethasone EP Impurity H) | C22H29FO5 | 185613-71-2 | Details |
Nintedanib impurity 03 | C56H52N8O8 | 2410284-90-9 | Details |
Budesonide Impurity 49 | C23H32O7 | 76282-98-9 | Details |
disodiumN-(carboxylatomethyl)-N-methylglycinate | C5H9NO4.2Na | 71160-37-7 | Details |
β-Alanine, N-(2-bromo-6-fluorophenyl)-, methyl ester | C10H11BrFNO2 | 1697691-31-8 | Details |
Rotigotine Impurity 5(Rotigotine USP RC H) | C20H27NOS | 1148154-91-9 | Details |
PSQ-IM-B | C17H17N5O2 | 1430561-06-0 | Details |
4-Bromo-n-methoxy-n,3-dimethylbenzamide | C10H12BrNO2 | 170230-01-0 | Details |
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- | C24H30O5 | 93239-37-3 | Details |
Methisosildenafil impure | C25H36N6O4S | 1425504-78-4 | Details |
Olmesartan Impurity 9 | C10H14N2O2 | 849206-42-4 | Details |
(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 4-methylbenzenesulfonate | C23H31N3O7S | 2136287-68-6 | Details |
dithiodesethylcarbodenafil | C22H28N6OS2 | 1610830-81-3 | Details |
1-Piperazineacetamide, N-(4-aminophenyl)-N-methyl- | C13H20N4O | 2243384-71-4 | Details |
Olmesartan Medoxomil Impurity G | C43H38N6O2 | 761404-82-4 | Details |
Loteprednol Impurity 5 | C25H34O7 | 182069-19-8 | Details |
Betamethasone Impurity 59 | C28H37FO7 | 5534-01-0 | Details |
3-OXO-4-AZAANDROST-5-EEN-17-BETA-CARBONZUUR | C19H27NO3 | 103335-54-2 | Details |
Prednisolone Impurity 7 | C21H26O6 | 61549-70-0 | Details |
Ezetimibe Impurity 78 | C30H35F2NO3Si | 942485-60-1 | Details |
Methylprednisolone Acetate EP Impurity D | C22H28O4 | 150899-33-5 | Details |
Cabozantinib Impurity 5 | C11H10ClNO3 | 2377278-36-7 | Details |
Linagliptin impurity KH-2 | C20H18BrN5O4 | 2279114-31-5 | Details |
4-[(E)-(4-hydroxyphenyl)azo]phenol | C12H10N2O2 | 51437-66-2 | Details |
2-amino-6-methylbenzenecarboximidamide | C8H11N3 | 1694987-11-5 | Details |
Hydrocortisone 21-Butyrate | C25H36O6 | 6677-99-2 | Details |
Cholan-24-amide, 3,7,12-trihydroxy-N,N-dimethyl-, (3α,5β,7α,12α)- | C26H45NO4 | 86678-85-5 | Details |
synthesis-1 | C9H8FNO2 | 1379423-29-6 | Details |
1H-Inden-1-one, 2,3-dihydro-3-hydroxy-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methylene]- | C24H27NO4 | 2097683-70-8 | Details |
Diazene, bis(4-fluorophenyl)-, (Z)- (9CI) | C12H8F2N2 | 51789-00-5 | Details |
1,5-Dibromo-1-(2-fluorophenyl)-2-pentanone | C11H11Br2FO | 1373350-57-2 | Details |
Dexamethasone Impurity 17 | C22H27FO4 | 59860-99-0 | Details |
Cabozantinib Impurity 38 | C19H18N2O4 | 651054-52-3 | Details |
Formamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- | C18H16N2O4 | 190728-28-0 | Details |
9-Bromo-11,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate | C23H31BrO6 | 50733-54-5 | Details |
3-O-Methylnaltrexone Ethylene Ketal | C23H29NO5 | 197242-23-2 | Details |
Product Total: Product Page: | ||||
81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 |